A share price of Hims & Hers Health Inc [HIMS] is currently trading at $27.85, down -0.32%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The HIMS shares have gain 9.60% over the last week, with a monthly amount drifted -10.88%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Hims & Hers Health Inc [NYSE: HIMS] stock has seen the most recent analyst activity on January 10, 2025, when Citigroup downgraded its rating to a Sell and also boosted its price target to $25 from $24. Previously, BTIG Research started tracking the stock with Buy rating on January 07, 2025, and set its price target to $35. On December 17, 2024, Morgan Stanley initiated with a Overweight rating and assigned a price target of $42 on the stock. BofA Securities downgraded its rating to a Underperform. Needham initiated its recommendation with a Buy and recommended $24 as its price target on August 22, 2024. Imperial Capital downgraded its rating to In-line for this stock on August 09, 2024. In a note dated May 22, 2024, Citigroup downgraded an Neutral rating on this stock and boosted its target price from $16 to $20.
Hims & Hers Health Inc experienced fluctuations in its stock price throughout the past year between $8.14 and $35.02. Currently, Wall Street analysts expect the stock to reach $24.67 within the next 12 months. Hims & Hers Health Inc [NYSE: HIMS] shares were valued at $27.85 at the most recent close of the market. An investor can expect a potential drop of -11.42% based on the average HIMS price forecast.
Analyzing the HIMS fundamentals
Trailing Twelve Months sales for Hims & Hers Health Inc [NYSE:HIMS] were 1.24B which represents 77.13% growth. Gross Profit Margin for this corporation currently stands at 0.78% with Operating Profit Margin at 0.03%, Pretax Profit Margin comes in at 0.04%, and Net Profit Margin reading is 0.08%. To continue investigating profitability, this company’s Return on Assets is posted at 0.17, Equity is 0.27 and Total Capital is 0.08. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.03.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 26.24 points at the first support level, and at 24.64 for the second support level. However, for the 1st resistance point, the stock is sitting at 28.77, and for the 2nd resistance point, it is at 29.70.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Hims & Hers Health Inc [NYSE:HIMS] is 2.14. As well, the Quick Ratio is 1.82, while the Cash Ratio is 1.08. Considering the valuation of this stock, the price to sales ratio is 4.90, the price to book ratio is 13.79 and price to earnings (TTM) ratio is 64.42.
Transactions by insiders
Recent insider trading involved Dudum Andrew, Officer, that happened on Jan 16 ’25 when 83994.0 shares were purchased. Chief Financial Officer, Okupe Oluyemi completed a deal on Jan 13 ’25 to sell 11581.0 shares. Meanwhile, Chief Commercial Officer Chi Michael sold 7259.0 shares on Jan 10 ’25.
